A citation-based method for searching scientific literature

Wan-Ming Hu, Fang Wang, Shao-Yan Xi, Xiao Zhang, Jun-Peng Lai, Hui-Yu Wu, Li-Ling Liu, Ke Sai, Jing Zeng. J Cancer 2020
Times Cited: 3







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
100

Expression of CPEB4 in Human Glioma and Its Correlations With Prognosis.
Wanming Hu, Yuanzhong Yang, Shaoyan Xi, Ke Sai, Dongfang Su, Xinke Zhang, Suxia Lin, Jing Zeng. Medicine (Baltimore) 2015
22
66

Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Shasha Liu, Chaoqi Zhang, Nomathamsanqa Resegofetse Maimela, Li Yang, Zhen Zhang, Yu Ping, Lan Huang, Yi Zhang. Oncoimmunology 2019
22
66

Genetic and molecular epidemiology of adult diffuse glioma.
Annette M Molinaro, Jennie W Taylor, John K Wiencke, Margaret R Wrensch. Nat Rev Neurol 2019
110
66

Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas.
H M Strik, M H Deininger, B Frank, H J Schluesener, R Meyermann. J Neurooncol 2001
36
33

Engineering strategies to mimic the glioblastoma microenvironment.
Andrew Rape, Badriprasad Ananthanarayanan, Sanjay Kumar. Adv Drug Deliv Rev 2014
70
33

Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3.
Kyueng-Whan Min, Moon Hyang Park, Sung Ran Hong, Heejung Lee, Sun Young Kwon, Sook Hee Hong, Hee Jae Joo, In Ae Park, Hee Jung An, Kwang Sun Suh,[...]. Int J Gynecol Pathol 2013
19
33

The 2016 World Health Organization classification of tumours of the central nervous system.
Chiara Villa, Catherine Miquel, Dominic Mosses, Michèle Bernier, Anna Luisa Di Stefano. Presse Med 2018
28
33

Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.
L Gordower, C Decaestecker, Y Kacem, A Lemmers, J Gusman, M Burchert, A Danguy, H Gabius, I Salmon, R Kiss,[...]. Neuropathol Appl Neurobiol 1999
57
33

Diagnostic and Prognostic Significance of Serum and Tissue Galectin 3 Expression in Patients with Carcinoma of the Bladder.
Hoda El Gendy, Bothina Madkour, Sara Abdelaty, Fayza Essawy, Dina Khattab, Olfat Hammam, Hani H Nour. Curr Urol 2014
10
33

Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
I Camby, N Belot, S Rorive, F Lefranc, C A Maurage, H Lahm, H Kaltner, Y Hadari, M M Ruchoux, J Brotchi,[...]. Brain Pathol 2001
140
33

Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.
Dubravka Matesa-Anić, Sandra Moslavac, Neven Matesa, Hrvoje Cupić, Zvonko Kusić. Acta Clin Croat 2012
7
33

Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
Luciano Neder, Suely K Nagahashi Marie, Carlos Gilberto Carlotti, Alberto Alain Gabbai, Sérgio Rosemberg, Suzana M F Malheiros, Rodrigo Proto Siqueira, Sueli Mieko Oba-Shinjo, Miyuki Uno, Paulo Henrique Aguiar,[...]. Brain Pathol 2004
32
33

Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.
Nobuko Serizawa, Jijing Tian, Hiroo Fukada, Kornelia Baghy, Fiona Scott, Xiangling Chen, Zsofia Kiss, Kristin Olson, Dan Hsu, Fu-Tong Liu,[...]. Lab Invest 2015
27
33

Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Jaudah Al-Maghrabi, Amer Shafie Abdelrahman, Tawfik Ghabrah, Nadeem Shafique Butt, Basim Al-Maghrabi, Mohamad Nidal Khabaz. Pathol Res Pract 2017
6
33

Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.
Valentina Vladimirova, Andreas Waha, Katharina Lückerath, Penka Pesheva, Rainer Probstmeier. J Neurosci Res 2008
44
33

Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.
Judith S Knapp, Soum D Lokeshwar, Ulrich Vogel, Jörg Hennenlotter, Christian Schwentner, Mario W Kramer, Arnulf Stenzl, Axel S Merseburger. World J Urol 2013
22
33

LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.
Hongxiang Wang, Xiao Song, Qilin Huang, Tao Xu, Dapeng Yun, Yuqi Wang, Lingna Hu, Yong Yan, Hongyan Chen, Daru Lu,[...]. Cancer Epidemiol Biomarkers Prev 2019
9
33


Genetics of adult glioma.
McKinsey L Goodenberger, Robert B Jenkins. Cancer Genet 2012
438
33

Galectin-3 is a presurgical marker of human thyroid carcinoma.
F Orlandi, E Saggiorato, G Pivano, B Puligheddu, A Termine, S Cappia, P De Giuli, A Angeli. Cancer Res 1998
181
33

Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer.
Tatsuo Shimura, Masahiko Shibata, Kenji Gonda, Takahiro Nakajima, Shun Chida, Masaru Noda, Satoshi Suzuki, Izumi Nakamura, Shinji Ohki, Seiichi Takenoshita. Biomed Rep 2016
13
33

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high‑grade glioma.
Kuanyu Wang, Ruoyu Huang, Guanzhang Li, Fan Zeng, Zheng Zhao, Yanwei Liu, Huimin Hu, Tao Jiang. Oncol Rep 2018
9
33

Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.
Pierpaolo Trimboli, Camilla Virili, Francesco Romanelli, Anna Crescenzi, Luca Giovanella. Int J Mol Sci 2017
19
33

The role of tumor-associated macrophage in tumor progression.
Koji Fukuda, Aya Kobayashi, Kounosuke Watabe. Front Biosci (Schol Ed) 2012
47
33

Crosstalk between M2 macrophages and glioma stem cells.
Leora M Nusblat, Molly J Carroll, Charles M Roth. Cell Oncol (Dordr) 2017
31
33

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.
Matthias Ilmer, Nachman Mazurek, Michael Z Gilcrease, James C Byrd, Wendy A Woodward, Thomas A Buchholz, Kim Acklin, Karen Ramirez, Margarete Hafley, Eckhard Alt,[...]. Breast Cancer Res 2016
18
33

Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).
Rui Dong, Min Zhang, Qunying Hu, Shan Zheng, Andrew Soh, Yijie Zheng, Hui Yuan. Int J Mol Med 2018
88
33


Serum galectin-3 as a potential marker for gastric cancer.
Daye Cheng, Bin Liang, Yunhui Li. Med Sci Monit 2015
18
33


Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
Stephania Libreros, Ramon Garcia-Areas, Yoshimi Shibata, Roberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu. Int J Cancer 2012
58
33

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.
Jake S O'Donnell, Daniela Massi, Michele W L Teng, Mario Mandala. Semin Cancer Biol 2018
129
33

Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage.
Eric Steck, Stephen Breit, Steffen J Breusch, Matthias Axt, Wiltrud Richter. Biochem Biophys Res Commun 2002
56
33


CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
Quinn T Ostrom, Haley Gittleman, Gabrielle Truitt, Alexander Boscia, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2018
744
33

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
33

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
Adília Hormigo, Bin Gu, Sasan Karimi, Elyn Riedel, Katherine S Panageas, Mark A Edgar, Meena K Tanwar, Jasti S Rao, Martin Fleisher, Lisa M DeAngelis,[...]. Clin Cancer Res 2006
124
33

Chitinase expression in Alzheimer's disease and non-demented brains regions.
C Sanfilippo, L Malaguarnera, M Di Rosa. J Neurol Sci 2016
19
33

M2 Macrophage Marker Chitinase 3-Like 2 (CHI3L2) Associates With Progression of Conventional Renal Cell Carcinoma.
Csaba Pusztai, Maria V Yusenko, Daniel Banyai, Arpad Szanto, Gyula Kovacs. Anticancer Res 2019
5
33

Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment.
Heidi Harjunpää, Marc Llort Asens, Carla Guenther, Susanna C Fagerholm. Front Immunol 2019
101
33

Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
D Yan, J Kowal, L Akkari, A J Schuhmacher, J T Huse, B L West, J A Joyce. Oncogene 2017
86
33

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
Carol A Colton, Ryan T Mott, Hayley Sharpe, Qing Xu, William E Van Nostrand, Michael P Vitek. J Neuroinflammation 2006
304
33

Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
Kai Xiao, Jun Tan, Jian Yuan, Gang Peng, Wenyong Long, Jun Su, Yao Xiao, Qun Xiao, Changwu Wu, Chaoying Qin,[...]. J Cell Mol Med 2020
3
33

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
33

Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
Qianquan Ma, Wenyong Long, Changsheng Xing, Junjun Chu, Mei Luo, Helen Y Wang, Qing Liu, Rong-Fu Wang. Front Immunol 2018
50
33

Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy.
Nikolai Litviakov, Matvey Tsyganov, Irina Larionova, Marina Ibragimova, Irina Deryusheva, Polina Kazantseva, Elena Slonimskaya, Irina Frolova, Eugeniy Choinzonov, Nadezhda Cherdyntseva,[...]. Cancer Chemother Pharmacol 2018
15
33

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
G Hinsinger, N Galéotti, N Nabholz, S Urbach, V Rigau, C Demattei, S Lehmann, W Camu, P Labauge, G Castelnovo,[...]. Mult Scler 2015
75
33

Human YKL39 (chitinase 3-like protein 2), an osteoarthritis-associated gene, enhances proliferation and type II collagen expression in ATDC5 cells.
Kazumasa Miyatake, Kunikazu Tsuji, Mika Yamaga, Jun Yamada, Yu Matsukura, Kahaer Abula, Ichiro Sekiya, Takeshi Muneta. Biochem Biophys Res Commun 2013
14
33

Role of chitinase-like proteins in cancer.
Julia Kzhyshkowska, Shuiping Yin, Tengfei Liu, Vladimir Riabov, Irina Mitrofanova. Biol Chem 2016
53
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.